I wonder what the impact will be on low code, no code tool. Why learn a stack that has to be mostly maintain manually when you can have Claude code do it.
19.10.2025 16:04
👍 0
🔁 0
💬 0
📌 0
I wonder what the impact will be on low code, no code tool. Why learn a stack that has to be mostly maintain manually when you can have Claude code do it.
The real competition for your docs? It's not that strong. Even basic docs beat digging through Slack or bugging teammates. You don't need perfect docs—just make them the fastest way to get things done. Are your docs the easiest option? ericmjl.github.io/blog/2025/7/... #documentation #productivity
NIH funding supporting the HMMER and Infernal software projects has been terminated. NIH states that our work, as well as all other federally funded research at Harvard, is of no benefit to the US.
Across New England and the country, thousands of budding scientists have awoken to a stark new reality, following funding cuts by the Trump Administration. - via @bostonglobe.com
buff.ly/XYK9bLh
Flash invariant point attention enables the generation of larger biomolecules.
arxiv.org/abs/2505.11580
From Likelihood to Fitness: Improving Variant Effect Prediction in Protein and Genome Language Models https://www.biorxiv.org/content/10.1101/2025.05.20.655154v1
Post-Hoc: AI's CRISPR moment
Both technologies are powerful and hold vast potential. But the AI bio field should learn lessons from the overhyped history of CRISPR in how its leaders set expectations:
endpts.com/post-hoc-ai-...
There are now a trio of great pieces covering the rapid rise of Chinese biotech:
- atelfo.github.io/2024/12/20/w...
- centuryofbio.com/p/commoditiz...
- www.asimov.press/p/china-trials
How to use Conda without running afoul of Anaconda licensing. Read more on our blog:
#bioinformatics #conda #software
open.substack.com/pub/fulcrumg...
A dark read from a biotech investor. Some important themes here about prioritizing shareholders substack.com/inbox/post/1...
This is horrible to post, but I may as well post it. We are essentially shutting down research operations in my group, which is focused on treatments for pediatric brain cancer. I’m a well funded investigator, and there’s no choice. Science can’t function without the stability of NIH
One of the most powerful moments of the day came from Emily Whitehead who told the story of how she was the first pediatric patient to receive CAR T-cell therapy for her leukemia at age 5: “I stand up for science because science saved my life. And that’s a fact.” @standupforscience.bsky.social
Screen shot of the article
For decades, the US government has painstakingly kept American science #1 globally—and every facet of American life has improved because of it. The internet? Flu shot? Ozempic? All grew out of federally-funded research. Now all that's being dismantled. 1/ www.technologyreview.com/2025/02/21/1...
It’s been a tough few weeks. My 10yo daughter was diagnosed with a very rare, aggressive cancer called interdigitating dendritic cell sarcoma (IDCS). I’m reaching out to identify clinicians/patients who have encountered pediatric IDCS or other (non-LCH) dendritic or histiocytic sarcomas cases.
Gold is basically data mart. Isn’t it?